Wardale, L.; Cardenas, R.; Gnanapragasam, V.J.; Cooper, C.S.; Clark, J.; Brewer, D.S.
Combining Molecular Subtypes with Multivariable Clinical Models Has the Potential to Improve Prediction of Treatment Outcomes in Prostate Cancer at Diagnosis. Curr. Oncol. 2023, 30, 157-170.
https://doi.org/10.3390/curroncol30010013
AMA Style
Wardale L, Cardenas R, Gnanapragasam VJ, Cooper CS, Clark J, Brewer DS.
Combining Molecular Subtypes with Multivariable Clinical Models Has the Potential to Improve Prediction of Treatment Outcomes in Prostate Cancer at Diagnosis. Current Oncology. 2023; 30(1):157-170.
https://doi.org/10.3390/curroncol30010013
Chicago/Turabian Style
Wardale, Lewis, Ryan Cardenas, Vincent J. Gnanapragasam, Colin S. Cooper, Jeremy Clark, and Daniel S. Brewer.
2023. "Combining Molecular Subtypes with Multivariable Clinical Models Has the Potential to Improve Prediction of Treatment Outcomes in Prostate Cancer at Diagnosis" Current Oncology 30, no. 1: 157-170.
https://doi.org/10.3390/curroncol30010013
APA Style
Wardale, L., Cardenas, R., Gnanapragasam, V. J., Cooper, C. S., Clark, J., & Brewer, D. S.
(2023). Combining Molecular Subtypes with Multivariable Clinical Models Has the Potential to Improve Prediction of Treatment Outcomes in Prostate Cancer at Diagnosis. Current Oncology, 30(1), 157-170.
https://doi.org/10.3390/curroncol30010013